Evaluation of Tumor Necrosis Factor inhibitor therapy in Susac syndrome

被引：0
|
作者：
Buelens, T.
Ossewaarde-van Norel, A.
Nubourgh, I.
Glibert, G.
Semeu, P. Kamgang
Caspers, L.
Postelmans, L.
Willermain, F.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2016年 / 94卷
关键词：
D O I：
10.1111/j.1755-3768.2016.0567
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Association of ethnicity, tumor necrosis factor inhibitor therapy, and myocardial infarction risk in patients with psoriasis
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (01) : 167 - 168
  • [42] Association of gender, tumor necrosis factor inhibitor therapy, and myocardial infarction risk in patients with psoriasis
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (04) : 650 - 651
  • [43] Development of Antinuclear Antibodies and Systemic Lupus Erythematosus in Patients on Tumor Necrosis Factor a Inhibitor Therapy
    Wijewardena, Chathura
    Pirinavan, Paramarajan
    Nasr, Sandy
    Perl, Andras
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3191 - 3193
  • [44] Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    Channual, Jennifer C.
    Shen, Albert Yuh-Jer
    ARCHIVES OF DERMATOLOGY, 2012, 148 (11) : 1244 - 1250
  • [45] Nonalcoholic fatty liver disease: a potential consequence of tumor necrosis factor-inhibitor therapy
    Feagins, Linda A.
    Flores, Avegail
    Arriens, Cristina
    Park, Christina
    Crook, Terri
    Reimold, Andreas
    Brown, Geri
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (10) : 1154 - 1160
  • [46] Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis
    Giles, JT
    Bartlett, SJ
    Gelber, AC
    Nanda, S
    Fontaine, K
    Ruffing, V
    Bathon, JM
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (02): : 333 - 337
  • [47] Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy
    Takahashi, Gen
    Kobayashi, Hiroyuki
    Saito, Yasuyuki
    Ohsawa, Sho
    Suzuki, Kuniaki
    Ishihara, Shinichi
    Hisada, Takeshi
    INTERNAL MEDICINE, 2019, 58 (24) : 3593 - 3596
  • [48] Disseminated Blastomycosis Following Initiation of Tumor Necrosis Factor Inhibitor Therapy for Crohn's Disease
    Purkey, Samuel C.
    Shorman, Mahmoud
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1020 - S1020
  • [49] Novel Variant of Miller Fisher Syndrome Occurring With Tumor Necrosis Factor α Antagonist Therapy
    Ratnarajan, Gokulan
    Thompson, Alexander
    Dodridge, Caroline
    Parry, Allyson
    Elston, John
    JAMA NEUROLOGY, 2015, 72 (11) : 1377 - 1378
  • [50] Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor a inhibitor therapy
    Han, Sun Ae
    Yoon, Young Min
    Lee, Wan Soo
    Kim, Yun Sung
    Shin, Byung Chul
    Chung, Jong Hoon
    Kim, Hyun Lee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03): : 601 - 604
12345